Crism Therapeutics (LSE:CRTX) Total Stockholders Equity : £2.07 Mil (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Total Stockholders Equity?

Crism Therapeutics's Total Stockholders Equity for the quarter that ended in Jun. 2024 was £2.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Crism Therapeutics's Book Value per Share for the quarter that ended in Jun. 2024 was £0.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Crism Therapeutics's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.00.

Crism Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Crism Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Total Stockholders Equity Chart

Crism Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

20.70

23.00

22.31

22.99

3.24

Crism Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															30.50	22.99	3.61	3.24	2.07

Crism Therapeutics (LSE:CRTX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Crism Therapeutics's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2.07	-	0)	/	32.678
	=	0.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Crism Therapeutics's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	2.07
	=	0.00

Crism Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB

Website

https://www.crismtherapeutics.com

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines